Template:Hallucinogens: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
en>Meodipt m Reverted edits by Hydroxyphencyclidine (talk) to last version by Lol1VNIO |
||
| Line 21: | Line 21: | ||
|list2= | |list2= | ||
* [[1B-LSD]]<!-- {{DOI|10.1007/s00216-018-1558-9}}. --> | * [[1B-LSD]]<!-- {{DOI|10.1007/s00216-018-1558-9}}. --> | ||
* [[ | * [[1cP-LSD]]<!-- doi:10.1002/dta.2789 --> | ||
* [[1P-ETH-LAD]] | * [[1P-ETH-LAD]] | ||
* [[1P-LSD]] | * [[1P-LSD]] | ||
* [[1cP-AL-LAD]] | |||
* [[1cP-MiPLA]] | |||
* [[1V-LSD]] | |||
* [[Lysergic acid 2-butyl amide|2-Butyllysergamide]] | * [[Lysergic acid 2-butyl amide|2-Butyllysergamide]] | ||
* [[Lysergic acid 3-pentyl amide|3-Pentyllysergamide]] | * [[Lysergic acid 3-pentyl amide|3-Pentyllysergamide]] | ||
| Line 39: | Line 42: | ||
* [[LPD-824]] | * [[LPD-824]] | ||
* [[Ergine|LSA]] | * [[Ergine|LSA]] | ||
* [[ | * [[LSD]] | ||
* [[LSD-Pip]] | * [[LSD-Pip]] | ||
* [[Lysergic acid hydroxyethylamide|LSH]] | * [[Lysergic acid hydroxyethylamide|LSH]] | ||
| Line 63: | Line 66: | ||
{{Navbox|subgroup | {{Navbox|subgroup | ||
|group1=25''x''-<abbr title="NB: N-benzyl | |group1=25''x''-<abbr title="NB: N-benzyl">NB</abbr> | ||
|list1= | |list1= | ||
* [[25B-NB]] | |||
* [[25C-NB]] | |||
|group2=25''x''-<abbr title="NB: N-benzyl; 3OMe: 3-methoxy">NB3OMe</abbr> | |||
|list2= | |||
* [[25B-NB3OMe]] | * [[25B-NB3OMe]] | ||
* [[25C-NB3OMe]] | * [[25C-NB3OMe]] | ||
| Line 78: | Line 86: | ||
* [[25TFM-NB3OMe]] | * [[25TFM-NB3OMe]] | ||
| | |group3=25''x''-<abbr title="NB: N-benzyl; 4OMe: 4-methoxy">NB4OMe</abbr> | ||
| | |list3= | ||
* [[25B-NB4OMe]] | * [[25B-NB4OMe]] | ||
* [[25C-NB4OMe]] | * [[25C-NB4OMe]] | ||
| Line 93: | Line 101: | ||
* [[25TFM-NB4OMe]] | * [[25TFM-NB4OMe]] | ||
|group4=25''x''-<abbr title="NB: N-benzyl; F: fluoro">NBF</abbr> | |||
| | |list4= | ||
| | |||
* [[25B-NBF]] | * [[25B-NBF]] | ||
* [[25C-NBF]] | * [[25C-NBF]] | ||
| Line 107: | Line 114: | ||
* [[25TFM-NBF]] | * [[25TFM-NBF]] | ||
| | |group5=25''x''-<abbr title="NB: N-benzyl; MD: methylenedioxy">NBMD</abbr> | ||
| | |list5= | ||
* [[25B-NBMD]] | * [[25B-NBMD]] | ||
* [[25C-NBMD]] | * [[25C-NBMD]] | ||
| Line 121: | Line 128: | ||
* [[25TFM-NBMD]] | * [[25TFM-NBMD]] | ||
| | |group6=25''x''-<abbr title="NB: N-benzyl; OH: hydroxy">NBOH</abbr> | ||
| | |list6= | ||
* [[25B-NBOH]] | * [[25B-NBOH]] | ||
* [[25C-NBOH]] | * [[25C-NBOH]] | ||
| Line 136: | Line 143: | ||
* [[25TFM-NBOH]] | * [[25TFM-NBOH]] | ||
| | |group7=25''x''-<abbr title="NB: N-benzyl; OMe: methoxy">NBOMe</abbr> | ||
| | |list7= | ||
* [[25B-NBOMe]] | * [[25B-NBOMe]] | ||
* [[25C-NBOMe]] | * [[25C-NBOMe]] | ||
| Line 150: | Line 157: | ||
* [[25N-NBOMe]] | * [[25N-NBOMe]] | ||
* [[25P-NBOMe]] | * [[25P-NBOMe]] | ||
* [[25T-NBOMe]] | |||
* [[25T2-NBOMe]] | * [[25T2-NBOMe]] | ||
* [[25T4-NBOMe]] | * [[25T4-NBOMe]] | ||
| Line 155: | Line 163: | ||
* [[25TFM-NBOMe]] | * [[25TFM-NBOMe]] | ||
| | |group8=Atypical structures | ||
| | |list8= | ||
* [[25B-N1POMe]] | |||
* [[25B-NAcPip]] | |||
* [[25B-NB23DM]] | |||
* [[25B-NB25DM]] | |||
* [[25C-NBCl]] | |||
* [[25C-NBOEt]] | |||
* [[25C-NBOiPr]] | |||
* [[25I-N2Nap1OH]] | |||
* [[25I-N3MT2M]] | |||
* [[25I-N4MT3M]] | |||
* [[25I-NB34MD]] | * [[25I-NB34MD]] | ||
* [[25I-NBAm]] | |||
* [[25I-NBBr]] | |||
* [[25I-NBMeOH]] | |||
* [[25I-NBTFM]] | |||
* [[2CBCB-NBOMe]] | * [[2CBCB-NBOMe]] | ||
* [[2CBFly-NBOMe]] | * [[2CBFly-NBOMe]] | ||
* [[4-EA-NBOMe]] | |||
* [[5-APB-NBOMe]] | |||
* [[5MT-NBOMe]] | |||
* [[C30-NBOMe]] | |||
* [[DOB-NBOMe]] | |||
* [[DOI-NBOMe]] | |||
* [[FECIMBI-36]] | |||
* [[MDPEA-NBOMe]] | |||
* [[N-Ethyl-2C-B]] | |||
* [[NBOMe-escaline]] | |||
* [[NBOMe-mescaline]] | * [[NBOMe-mescaline]] | ||
* [[ZDCM-04]] | |||
}} | }} | ||
|group2=25''x''-NM''x'' | |||
|list2= | |||
* [[25B-NMe7BF]] | |||
* [[25B-NMe7BT]] | |||
* [[25B-NMe7Bim]] | |||
* [[25B-NMe7Box]] | |||
* [[25B-NMe7DHBF]] | |||
* [[25B-NMe7Ind]] | |||
* [[25B-NMe7Indz]] | |||
* [[25B-NMePyr]] | |||
* [[25I-NMe7DHBF]] | |||
* [[25I-NMeFur]] | |||
* [[25I-NMeTHF]] | |||
* [[25I-NMeTh]] | |||
|group3=[[N-(2C)-fentanyl]] | |||
|list3= | |||
* [[N-(2C-B) fentanyl]] | |||
* [[N-(2C-C) fentanyl]] | |||
* [[N-(2C-D) fentanyl]] | |||
* [[N-(2C-E) fentanyl]] | |||
* [[N-(2C-G) fentanyl]] | |||
* [[N-(2C-H) fentanyl]] | |||
* [[N-(2C-I) fentanyl]] | |||
* [[N-(2C-IP) fentanyl]] | |||
* [[N-(2C-N) fentanyl]] | |||
* [[N-(2C-P) fentanyl]] | |||
* [[N-(2C-T) fentanyl]] | |||
* [[N-(2C-T-2) fentanyl]] | |||
* [[N-(2C-T-4) fentanyl]] | |||
* [[N-(2C-T-7) fentanyl]] | |||
* [[N-(2C-TFM) fentanyl]] | |||
}} | }} | ||
| Line 170: | Line 237: | ||
* [[3C-DFE]] | * [[3C-DFE]] | ||
* [[3C-E]] | * [[3C-E]] | ||
* [[3C-MAL]] | |||
* [[3C-P]] | * [[3C-P]] | ||
| Line 175: | Line 243: | ||
|list4= | |list4= | ||
* [[4C-B]] | * [[4C-B]] | ||
* [[4C-C]] | |||
* [[4C-D]] | * [[4C-D]] | ||
* [[4C-E]] | |||
* [[4C-I]] | |||
* [[4C-N]] | |||
* [[4C-P]] | |||
* [[4C-T-2]] | * [[4C-T-2]] | ||
| Line 206: | Line 279: | ||
* [[Lophophine]] | * [[Lophophine]] | ||
* [[3,4-Methylenedioxyamphetamine|MDA]] | * [[3,4-Methylenedioxyamphetamine|MDA]] | ||
* [[MDAI]] | |||
* [[MDBZ]] | |||
* [[MDMA]] | |||
* [[MMDA (drug)|MMDA]] | * [[MMDA (drug)|MMDA]] | ||
* [[MMDA-2]] | * [[MMDA-2]] | ||
| Line 250: | Line 326: | ||
* [[2C-B-BUTTERFLY]] | * [[2C-B-BUTTERFLY]] | ||
* [[2C-B-DragonFLY]] | * [[2C-B-DragonFLY]] | ||
* [[2C-B-DragonFLY-NBOH]] | |||
* [[2C-B-FLY-NB2EtO5Cl]] | |||
* [[2CB-5-hemifly]] | * [[2CB-5-hemifly]] | ||
* [[2CB-Ind]] | * [[2CB-Ind]] | ||
| Line 275: | Line 353: | ||
|group4= [[Substituted piperazine|Piperazine]]s | |group4= [[Substituted piperazine|Piperazine]]s | ||
|list4= | |list4= | ||
* [[2C-B-PP]] | |||
* [[Benzylpiperazine|BZP]] | * [[Benzylpiperazine|BZP]] | ||
* [[para-Fluorophenylpiperazine|pFPP]] | * [[para-Fluorophenylpiperazine|pFPP]] | ||
| Line 341: | Line 420: | ||
* [[5-MeO-DPT]] | * [[5-MeO-DPT]] | ||
* [[Dipropyltryptamine|(The Light) DPT]] | * [[Dipropyltryptamine|(The Light) DPT]] | ||
|group7=Ibogaine-related | |group7=Ibogaine-related | ||
|list7= | |list7= | ||
| Line 398: | Line 477: | ||
* [[Lorcaserin]] | * [[Lorcaserin]] | ||
* [[M-ALPHA]] | * [[M-ALPHA]] | ||
* [[RH-34]]<br /><small>Also [[empathogen-entactogen|empathogens]] in general (e. g.: [[5-APB]], [[5-MAPB]], [[6-APB]] and other [[substituted benzofuran]]s | * [[RH-34]]<br /><small>Also [[empathogen-entactogen|empathogens]] in general (e. g.: [[5-APB]], [[5-MAPB]], [[6-APB]] and other [[substituted benzofuran]]s).</small> | ||
}} | }} | ||
| Line 415: | Line 494: | ||
|list2= {{PCP-related arylcyclohexylamines list}} | |list2= {{PCP-related arylcyclohexylamines list}} | ||
|group3= Others | |group3= Others | ||
|list3= | |list3= | ||
* [[BTCP]] | * [[BTCP]] | ||
* [[Gacyclidine]] | * [[Gacyclidine]] | ||
| Line 421: | Line 500: | ||
}} | }} | ||
|group8= | |group8= [[Adamantane]]s | ||
|list8= | |list8= | ||
* [[Amantadine]] | |||
* [[Memantine]] | |||
* [[Rimantadine]] | |||
|group9= Diarylethylamines | |||
|list9= | |||
* [[Diphenidine]] | * [[Diphenidine]] | ||
* [[Ephenidine]] | * [[Ephenidine]] | ||
| Line 428: | Line 513: | ||
* [[Methoxphenidine]] | * [[Methoxphenidine]] | ||
| | |group10= [[Morphinan]]s | ||
| | |list10= | ||
* [[Dextrallorphan]] | * [[Dextrallorphan]] | ||
* [[Dextromethorphan]] | * [[Dextromethorphan]] | ||
| Line 436: | Line 521: | ||
* [[Racemorphan]] | * [[Racemorphan]] | ||
| | |group11= Others | ||
| | |list11= | ||
* [[2-EMSB]] | * [[2-EMSB]] | ||
* [[2-MDP]] | * [[2-MDP]] | ||
| Line 495: | Line 580: | ||
* [[EA-3580]] | * [[EA-3580]] | ||
* [[EA-3834]] | * [[EA-3834]] | ||
* [[Flavoxate]] | * [[Flavoxate]] | ||
* [[Hyoscyamine]] | * [[Hyoscyamine]] | ||
| Line 502: | Line 586: | ||
* [[Meclozine]] | * [[Meclozine]] | ||
* [[Mepyramine]] | * [[Mepyramine]] | ||
* [[Orphenadrine]] | * [[Orphenadrine]] | ||
* [[Oxybutynin]] | * [[Oxybutynin]] | ||
| Line 762: | Line 845: | ||
* [[Cabergoline]] | * [[Cabergoline]] | ||
* [[Lisuride]] | * [[Lisuride]] | ||
* [[ | * [[LSD]] | ||
* [[Memantine]] | * [[Memantine]] | ||
* [[Nuciferine]] | * [[Nuciferine]] | ||
| Line 850: | Line 933: | ||
* [[Isoaminile]] | * [[Isoaminile]] | ||
* [[Noscapine]] | * [[Noscapine]] | ||
* [[Prenoxdiazine]] | |||
* [[Pukateine]] | * [[Pukateine]] | ||
}} | }} | ||
}}<noinclude> | }}<noinclude> | ||
{{ | {{navbox documentation}} | ||
[[Category:Psychoactive drug | [[Category:Psychoactive drug navigational boxes]] | ||
</noinclude> | </noinclude> | ||
